{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:39:55Z","timestamp":1782830395016,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Gait disorder is one of the clinical manifestations of Parkinson\u2019s disease (PD). Investigating the characteristics of gait disorder in patients with PD and the changes in gait before and after taking levodopa is crucial for the recognition, diagnosis and treatment of gait disorders in PD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we measured the gait parameters of 20 patients with PD and 17 healthy controls and analyzed the changes of gait parameters of these patients before and after taking levodopa. We also used gait parameters as input features and MDS-UPDRS III score (which was further subdivided into tremor and non-tremor part score) as output labels to train machine learning regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found that except for cadence and stride time, most gait parameters of PD patients, including plantar dorsiflexion angle, plantar flexion angle, stride length, velocity were all smaller than those of the healthy controls. Moreover, the severity of gait disorders correlated with the severity of motor symptoms. After taking levodopa, the stride length, velocity and cadence were increased, but stride time was decreased. We also found that the trained machine learning model could explain and predict the MDS-UPDRS III score and non-tremor part score, and the non-tremor part score was better than the MDS-UPDRS III score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our gait assessment work can help clinicians recognize gait disorder in PD patients and predict the severity of clinical symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1527020","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:51Z","timestamp":1755663291000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative analysis of gait parameters in Parkinson\u2019s disease and the clinical significance"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenchao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beichen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front Public Health"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson's disease genetics and pathophysiology","volume":"44","author":"V\u00e1zquez-V\u00e9lez","year":"2021","journal-title":"Annu Rev Neurosci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41401-020-0365-y","article-title":"Recent advances in dopaminergic strategies for the treatment of Parkinson\u2019s disease","volume":"41","author":"Mao","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2018.07.008","article-title":"Gait characteristics and falls in Parkinson's disease: a systematic review and meta-analysis","volume":"57","author":"Creaby","year":"2018","journal-title":"Parkinsonism Relat D"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21659","article-title":"Freezing of gait affects quality of life of peoples with Parkinson\u2019s disease beyond its relationships with mobility and gait","volume":"22","author":"Moore","year":"2007","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson\u2019s disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann Agr Env Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"916971","DOI":"10.3389\/fnagi.2022.916971","article-title":"Detection and assessment of Parkinson\u2019s disease based on gait analysis: a survey","volume":"14","author":"Guo","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1016\/j.jbiomech.2010.07.003","article-title":"3D gait assessment in young and elderly subjects using foot-worn inertial sensors","volume":"43","author":"Mariani","year":"2010","journal-title":"J Biomech"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/s18020676","article-title":"An automatic gait feature extraction method for identifying gait asymmetry using wearable sensors","volume":"18","author":"Anwary","year":"2018","journal-title":"Sensors"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","article-title":"Gait impairments in Parkinson\u2019s disease","volume":"18","author":"Mirelman","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.apmr.2004.08.012","article-title":"Quantitative gait analysis in Parkinson\u2019s disease: comparison with a healthy control group","volume":"86","author":"Sofuwa","year":"2005","journal-title":"Arch Phys Med Rehab."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41598-020-80768-2","article-title":"Gait parameters of Parkinson\u2019s disease compared with healthy controls: a systematic review and meta-analysis","volume":"11","author":"Zanardi","year":"2021","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.26269","article-title":"Levodopa is a double-edged sword for balance and gait in people with Parkinson\u2019s disease","volume":"30","author":"Curtze","year":"2015","journal-title":"Movement Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.apmr.2017.01.023","article-title":"Anticipatory postural adjustment during self-initiated, cued and compensatory stepping in healthy elderly and patients with Parkinson\u2019s disease","volume":"98","author":"Schlenstedt","year":"2017","journal-title":"Arch Phys Med Rehab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1109\/JBHI.2015.2419317","article-title":"Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson\u2019s disease: toward clinical and at home use","volume":"20","author":"Din","year":"2016","journal-title":"IEEE J Biomed Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including Opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov Disord Clin Prac"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1109\/TIM.2015.2504078","article-title":"Using distributed wearable sensors to measure and evaluate human lower limb motions","volume":"65","author":"Qiu","year":"2016","journal-title":"IEEE T Instrum Meas"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3233\/JPD-202129","article-title":"Clinical relevance of standardized Mobile gait tests-reliability analysis between gait recordings at hospital and home in Parkinson's disease: a pilot study","volume":"10","author":"Ga\u00dfner","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijge.2013.03.005","article-title":"Gait disorders in Parkinson\u2019s disease: assessment and management","volume":"7","author":"Chen","year":"2013","journal-title":"Int J Gerontol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.4081\/ni.2018.7729","article-title":"Quantitative assessment of gait parameters in people with Parkinson\u2019s disease in laboratory and clinical setting: are the measures interchangeable?","volume":"10","author":"Pau","year":"2018","journal-title":"Neurol Int"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/AOMD.AOMD_19_18","article-title":"Analysis of gait in Parkinson\u2019s disease reflecting the effect of l-DOPA","volume":"2","author":"Mondal","year":"2018","journal-title":"Ann Mov Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0022-510X(91)90283-D","article-title":"Dopa-sensitive and Dopa-resistant gait parameters in Parkinson's disease","volume":"103","author":"Blin","year":"1991","journal-title":"J Neurol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.1111\/ejn.15522","article-title":"The effects of levodopa in the spatiotemporal gait parameters are mediated by self-selected gait speed in Parkinson\u2019s disease","volume":"54","author":"Oliveira","year":"2021","journal-title":"Eur J Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.07.006","article-title":"Pharmacological treatment in Parkinson's disease: effects on gait","volume":"31","author":"Smulders","year":"2016","journal-title":"Parkinsonism Relat D."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1053\/apmr.2001.24893","article-title":"Gait variability and fall risk in community-living older adults: a 1-year prospective study","volume":"82","author":"Hausdorff","year":"2001","journal-title":"Arch Phys Med Rehab."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13643-019-1063-z","article-title":"Effects of walking speed on gait biomechanics in healthy participants: a systematic review and meta-analysis","volume":"8","author":"Fukuchi","year":"2019","journal-title":"Syst Rev London"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0183989","DOI":"10.1371\/journal.pone.0183989","article-title":"Wearable sensors objectively measure gait parameters in Parkinson\u2019s disease","volume":"12","author":"Schlachetzki","year":"2017","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2976535","DOI":"10.1155\/2020\/2976535","article-title":"Wearable sensors measure ankle joint changes of patients with Parkinson\u2019s disease before and after acute levodopa challenge","volume":"2020","author":"Wu","year":"2020","journal-title":"Parkinsons Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.medengphy.2012.04.016","article-title":"A self-adaptive foot-drop corrector using functional electrical stimulation (FES) modulated by tibialis anterior electromyography (EMG) dataset","volume":"35","author":"Chen","year":"2013","journal-title":"Med Eng Phys"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.gaitpost.2010.12.020","article-title":"Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson\u2019s disease","volume":"33","author":"Caliandro","year":"2011","journal-title":"Gait Posture"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.gaitpost.2018.03.046","article-title":"Objective measures of unobstructed walking and obstacle avoidance in Parkinson's disease subtypes","volume":"62","author":"Orcioli-Silva","year":"2018","journal-title":"Gait Posture"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2147\/NDT.S266585","article-title":"Can quantitative gait analysis be used to guide treatment of patients with different subtypes of Parkinson's disease?","volume":"16","author":"Wu","year":"2020","journal-title":"Neuropsych Dis Treat"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"237248","DOI":"10.1007\/BF01273184","article-title":"Gait quantitation in Parkinson's disease - locomotor disability and correlation to clinical rating scales","volume":"104","author":"Vieregge","year":"1997","journal-title":"J Neural Transm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.gaitpost.2021.10.029","article-title":"Surrogates for rigidity and PIGD MDS-UPDRS subscores using wearable sensors","volume":"91","author":"Safarpour","year":"2022","journal-title":"Gait Posture"},{"key":"ref37","first-page":"249","article-title":"Predicting the progression of Parkinson's disease MDS-UPDRS-III motor severity score from gait data using deep learning","author":"Rehman","year":"2021"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/s24113613","article-title":"Optimizing rare disease gait classification through data balancing and generative AI: insights from hereditary cerebellar Ataxia","volume":"24","author":"Trabassi","year":"2024","journal-title":"Sensors"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1527020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T04:14:52Z","timestamp":1755663292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1527020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":38,"alternative-id":["10.3389\/fneur.2025.1527020"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1527020","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"article-number":"1527020"}}